BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 9721799)

  • 41. Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS).
    Gruessner AC; Sutherland DE
    Clin Transpl; 1997; ():45-59. PubMed ID: 9919390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
    Ruggenenti P; Cravedi P; Gotti E; Plati A; Marasà M; Sandrini S; Bossini N; Citterio F; Minetti E; Montanaro D; Sabadini E; Tardanico R; Martinetti D; Gaspari F; Villa A; Perna A; Peraro F; Remuzzi G
    PLoS Med; 2021 Jun; 18(6):e1003668. PubMed ID: 34166370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study.
    Boillot O; Seket B; Dumortier J; Pittau G; Boucaud C; Bouffard Y; Scoazec JY
    Liver Transpl; 2009 Nov; 15(11):1426-34. PubMed ID: 19877264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group.
    Stratta RJ
    Transplant Proc; 1997; 29(1-2):654-5. PubMed ID: 9123463
    [No Abstract]   [Full Text] [Related]  

  • 45. Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens.
    Girman P; Lipar K; Koznarova R; Boucek P; Kriz J; Kocik M; Havrdova T; Adamec M; Saudek F
    Transplant Proc; 2010; 42(6):1999-2002. PubMed ID: 20692391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.
    Feng JJ; Zhang LW; Zhao P; Bow LM; Tian J
    Int J Clin Pract Suppl; 2015 May; (183):1-7. PubMed ID: 26176848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreas after kidney transplants.
    Humar A; Ramcharan T; Kandaswamy R; Matas A; Gruessner RW; Gruessner AC; Sutherland DE
    Am J Surg; 2001 Aug; 182(2):155-61. PubMed ID: 11574088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic rejection: the next major challenge for pancreas transplant recipients.
    Humar A; Khwaja K; Ramcharan T; Asolati M; Kandaswamy R; Gruessner RW; Sutherland DE; Gruessner AC
    Transplantation; 2003 Sep; 76(6):918-23. PubMed ID: 14508354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Similar results with solitary pancreas transplantation compared with simultaneous pancreas-kidney transplantation in the new millennium.
    Stratta RJ; Farney AC; Orlando G; Farooq U; Al-Shraideh Y; Rogers J
    Transplant Proc; 2014; 46(6):1924-7. PubMed ID: 25131072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
    Phanish MK; Hull RP; Andrews PA; Popoola J; Kingdon EJ; MacPhee IAM;
    BMC Nephrol; 2020 Mar; 21(1):92. PubMed ID: 32160893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excellent outcomes can be achieved in young pancreas transplant alone recipients by addition of sirolimus to maintenance immunosuppression regimen.
    Porubsky M; Gruessner AC; Rana A; Jie T; Gruessner RW
    Transplant Proc; 2014; 46(6):1932-5. PubMed ID: 25131074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
    Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.
    Wiesner R; Rabkin J; Klintmalm G; McDiarmid S; Langnas A; Punch J; McMaster P; Kalayoglu M; Levy G; Freeman R; Bismuth H; Neuhaus P; Mamelok R; Wang W
    Liver Transpl; 2001 May; 7(5):442-50. PubMed ID: 11349266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants.
    Hesse UJ; Troisi R; Jacobs B; Van Vlem B; de Hemptinne B; Van Holder R; Vermassen F; De Roose J; Lameire N
    Clin Transplant; 2000 Aug; 14(4 Pt 1):340-4. PubMed ID: 10945205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Sirolimus Combined With Tacrolimus and Mycophenolate Mofetil Combined With Tacrolimus in Kidney Transplantation Recipients: A Meta-Analysis.
    Gao L; Xu F; Cheng H; Liu J
    Transplant Proc; 2018 Dec; 50(10):3306-3313. PubMed ID: 30577200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical complications requiring early relaparotomy after pancreas transplantation: a multivariate risk factor and economic impact analysis of the cyclosporine era.
    Troppmann C; Gruessner AC; Dunn DL; Sutherland DE; Gruessner RW
    Ann Surg; 1998 Feb; 227(2):255-68. PubMed ID: 9488525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.
    Jungraithmayr T; Staskewitz A; Kirste G; Böswald M; Bulla M; Burghard R; Dippell J; Greiner C; Helmchen U; Klare B; Klaus G; Leichter HE; Mihatsch MJ; Michalk DV; Misselwitz J; Plank C; Querfeld U; Weber LT; Wiesel M; Tönshoff B; Zimmerhackl LB;
    Transplantation; 2003 Feb; 75(4):454-61. PubMed ID: 12605109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.
    Ciancio G; Sageshima J; Chen L; Gaynor JJ; Hanson L; Tueros L; Montenora-Velarde E; Gomez C; Kupin W; Guerra G; Mattiazzi A; Fornoni A; Pugliese A; Roth D; Wolf M; Burke GW
    Am J Transplant; 2012 Dec; 12(12):3363-76. PubMed ID: 22946986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.